About PharmaIN
PharmaIN is a company based in Bothell (United States) founded in 2001.. PharmaIN has raised $1.5 million across 21 funding rounds from investors including HHS. PharmaIN offers products and services including PHIN-214 and Proprietary Peptide Drugs. PharmaIN operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Bothell, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmain Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.5 M (USD)
in 21 rounds
-
Latest Funding Round
$1.99 M (USD), Grant
Jun 01, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PharmaIN
PharmaIN offers a comprehensive portfolio of products and services, including PHIN-214 and Proprietary Peptide Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapy for in-home treatment of liver disease and cancer.
Drugs designed for in-home management of chronic diseases like cirrhosis.
Unlock access to complete
Funding Insights of PharmaIN
PharmaIN has successfully raised a total of $1.5M across 21 strategic funding rounds. The most recent funding activity was a Grant round of $1.99 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Grant — $2.0M
-
First Round
First Round
(01 Jun 2004)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Grant - PharmaIN | Valuation |
investors |
|
| Jun, 2022 | Amount | Grant - PharmaIN | Valuation |
investors |
|
| Jun, 2017 | Amount | Grant - PharmaIN | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PharmaIN
PharmaIN has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PharmaIN
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PharmaIN
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmain Comparisons
Competitors of PharmaIN
PharmaIN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmain
Frequently Asked Questions about PharmaIN
When was PharmaIN founded?
PharmaIN was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Where is PharmaIN located?
PharmaIN is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Is PharmaIN a funded company?
PharmaIN is a funded company, having raised a total of $1.5M across 21 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Jun 01, 2004.
What does PharmaIN do?
Founded in 2001 and based in Bothell, United States, PharmaIN operates in the biotechnology sector. Proprietary technology platforms, including Protected Graft Copolymer (PGC) and various core binding moieties, are utilized to enhance active pharmaceutical ingredients and enable drug delivery. Preclinical products in development include PHIN-1138 for congestive heart failure, PHIN-1722 for diabetes and obesity, PHIN-438 for auto-immune disease, and PHIN-103 for ascites and hepato-renal syndrome.
Who are the top competitors of PharmaIN?
PharmaIN's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does PharmaIN offer?
PharmaIN offers PHIN-214 and Proprietary Peptide Drugs.
Who are PharmaIN's investors?
PharmaIN has 1 investor. Key investors include HHS.